Abstract
Despite many pharmacological and immunological treatments for asthma, some patients remain not well-controlled and continue to experience asthma exacerbations. Existing FDA-approved treatments for asthma do not address excessive airway smooth muscle mass (ASM), an anatomical feature associated with increased asthma severity and morbidity in some patients. We sought to examine the cost-effectiveness of Bronchial Thermoplasty (BT) to treat poorly controlled, severe, persistent asthma patients. This novel technology uses thermal energy to target and reduce ASM, resulting in a durable reduction in asthma exacerbations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
